FDA Let Drugs Approved on Fraudulent Research Stay on the Market
The agency refuses to disclose the names of the drugs it is reassessing, on the grounds that doing so would expose "confidential commercial information." But here are five drugs that used the controversial tests to help win FDA approval.
